ATC Group: J05AJ02 Elvitegravir

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of J05AJ02 in the ATC hierarchy

Level Code Title
1 J Antiinfectives for systemic use
2 J05 Antivirals for systemic use
3 J05A Direct acting antivirals
4 J05AJ Integrase inhibitors
5 J05AJ02

Active ingredients in J05AJ02

Active Ingredient Description
Elvitegravir

Elvitegravir, is a type of antiviral agent called an โ€˜integrase inhibitorโ€™. It blocks an enzyme called integrase, which is involved in a step in the reproduction of HIV. When the enzyme is blocked, the virus cannot reproduce normally, slowing down the spread of infection.

Medicines in this ATC group

Estonia (EE)

Lithuania (LT)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.